Status:
UNKNOWN
ARTHR-IS (Arthroplasties' Infections Due to Staphylococcus Aureus)
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborating Sponsors:
GlaxoSmithKline
Hospital Universitario Virgen Macarena
Conditions:
Staphylococcus Aureus
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
The number of arthroplasties is expected to grow in the next few years. Staphylococcus aureus (SA) is a primary cause of prosthetic joint infection (PJI) with serious consequences. This microorganism ...
Eligibility Criteria
Inclusion
- Patients who underwent a primary hip or knee arthroplasty between 2013 and 2016.
- Diagnosis of SA -PJI in the first 12 months after primary arthroplasty.
Exclusion
- • Patients with a previous SA infection or prosthesis revision on the index joint (joint which was replaced during arthroplasty).
Key Trial Info
Start Date :
April 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03826108
Start Date
April 16 2019
End Date
December 31 2020
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen Macarena
Seville, Andalusia, Spain, 41009